1. WHO—World Health Organization (2020) Estimated number of incident cases from 2018 to 2040. International Agency for Research on Cancer. Available in: https://gco.iarc.fr/tomorrow/graphic-isotype?type=0&type_sex=0&mode=population&sex=0&populations=900&cancers=36&age_group=value&apc_male=0&apc_female=0&single_unit=100000&print=0. Accessed Sep 17 2021.
2. Rosa LM, Hames ME, Dias M, Miranda GM, Bagio CB, Santos MJ, Kalinke LP. Epidemiological profile of women with gynecological cancer in brachytherapy: a cross-sectional study. Rev Bras Enferm. 2021;74(5):e20200695. https://doi.org/10.1590/0034-7167-2020-0695.
3. Watson M, Saraiya M, Wu X. Update of HPV-associated female genital cancers in the United States, 1999–2004. J Women's Health. 2009;18(11):1731–8. https://doi.org/10.1089/jwh.2009.1570.
4. Mann L, Foley KL, Tanner AE, Sun CJ, Rhodes SD. Increasing cervical cancer screening among US Hispanics/Latinas: a qualitative systematic review. J Cancer Educ. 2015;30(2):374–87. https://doi.org/10.1007/s13187-014-0716-9.
5. CDCP—Centers for Disease Control and Prevention (2019) gynecologic cancer incidence, United States—2012–2016. USCS data brief, no 11. Centers for Disease Control and Prevention, US Department of Health and Human Services. Atlanta, Georgia.